Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | RECQL | P46063 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | TTR | P02766 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | BCHE | P06276 | 1/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8996324 | 0.74 | FTO (0.68) | MAPTKDM4ERECQLALDH1A1TSHR | |
| Rhein SCHEMBL5076596 | 0.74 | ALDH1A1 (0.82) | MAPTKDM4ERECQLALDH1A1TSHR | |
| SCHEMBL8963432 | 0.72 | ALDH1A1 (0.57) | MAPTKDM4ERECQLALDH1A1TSHR | |
| SCHEMBL2148493 | 0.72 | ALDH1A1 (0.51) | MAPTKDM4ERECQLALDH1A1TSHR | |
| SCHEMBL29030333 | 0.72 | SLC37A4 (0.45) | MAPTKDM4ERECQLALDH1A1TSHR | |
| SCHEMBL16458915 | 0.71 | MEN1 (0.53) | MAPTKDM4ERECQLALDH1A1TSHR | |
| SCHEMBL28933782 | 0.70 | SLC37A4 (0.57) | MAPTKDM4ERECQLALDH1A1TSHR | |
| SCHEMBL25211546 | 0.69 | JUN (0.56) | MAPTKDM4ERECQLALDH1A1TSHR | |
| SCHEMBL28319049 | 0.68 | SLC37A4 (0.51) | MAPTKDM4ERECQLALDH1A1TSHR | |
| SCHEMBL23723959 | 0.67 | FTO (0.73) | MAPTKDM4ERECQLALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9321804-B2 | Synthesis and use of anti-tumor drug LQC-Y | 3D MEDICINES, LTD. (CN) | 2016-04-26 | — | — | US | disclosed |
| US-20140011786-A1 | SYNTHESIS AND USE OF ANTI-TUMOR DRUG LQC-Y | 3D MEDICINES, LTD. (CN) | 2014-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140011786-A1 | SYNTHESIS AND USE OF ANTI-TUMOR DRUG LQC-Y | HCCS, GLS2, SQLE | MAPT 4839/4885KDM4E 1206/4885RECQL 774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.